AdamCapital Gestao de Recursos’s Regeneron Pharmaceuticals REGN Stock Holding History

AdamCapital Gestao de Recursos’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-97,753	Closed	-$36.5M	–	14
2018 Q4	$36.5M	Buy	97,753 +10,673	+12%	+$3.91M	2.44%	10
2018 Q3	$35.2M	Sell	87,080 -19,495	-18%	-$7.42M	2.26%	11
2018 Q2	$36.8M	Sell	106,575 -43,550	-29%	-$13.6M	1.86%	15
2018 Q1	$51.7M	Buy	150,125 +72,320	+93%	+$25.2M	1.84%	11
2017 Q4	$29.3M	Buy	+77,805	New	+$31.5M	1.69%	16

Other funds holding REGN

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

AdamCapital Gestao de Recursos's REGN Position: Q1 2019 in Review

AdamCapital Gestao de Recursos sold out of Regeneron Pharmaceuticals (REGN) in Q1 2019, closing a stake of 97,753 shares — an estimated $36.5M sold.

AdamCapital Gestao de Recursos first reported a position in REGN in Q4 2017 and held it in 5 quarters. The position peaked at $51.7M in Q1 2018. 718 funds tracked by Wall St. Rank hold REGN as of Q1 2019.

AdamCapital Gestao de Recursos reported no remaining Regeneron Pharmaceuticals position as of Q1 2019 after selling out during the quarter.
AdamCapital Gestao de Recursos sold 97,753 Regeneron Pharmaceuticals shares in Q1 2019, an estimated $36.5M.
AdamCapital Gestao de Recursos first reported a position in Regeneron Pharmaceuticals in Q4 2017 and held it in 5 quarters.
AdamCapital Gestao de Recursos's Regeneron Pharmaceuticals position peaked at $51.7M in Q1 2018.
718 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2019.

Based on AdamCapital Gestao de Recursos's 13F filing for Q1 2019, filed 30 Apr 2019.